Genome-Wide Association Studies (GWAS)

Key advantages

• Detects common variants (SNPs) associated with complex traits and diseases

• High-throughput analysis across thousands of samples and millions of markers

• Applicable to humans, plants, animals, and microbial populations

• Supports population-scale studies with robust statistical power

• Enables precision breeding, pharmacogenomics, and biomarker discovery

• Integrates easily with phenotypic, clinical, and environmental data

• Supports replication and meta-analysis across cohorts and consortia

• Scalable for case-control, quantitative trait, and longitudinal study designs

Technical specifications

• Input data: genotyping arrays, WGS, WES, or imputed variant datasets (VCF, PLINK format)

• Analysis tools: PLINK, GEMMA, GCTA, BOLT-LMM, and custom pipelines

• Statistical models: logistic/linear regression, mixed models, principal component adjustment

• Outputs: Manhattan plots, QQ plots, summary statistics, genome-wide significance tables

• Custom filters: MAF thresholds, Hardy-Weinberg equilibrium, missingness, and LD pruning

• Supports population structure correction and covariate adjustment

• Optional integration with functional annotation, gene set enrichment, and pathway analysis

• Secure and scalable computation for large cohort analysis using cloud/HPC infrastructure